AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Validation of the French Version of the QASCI in Caregivers of Patients With COPD

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Brest
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to validate the French version of the QASCI questionnaire, initially written and validated in Portuguese language by Hipolito et al., to assess caregiving burden in chronic obstructive pulmonary disease (COPD). The realization of this validation is significant on several levels. First, since COPD is a systemic condition, it affects not only the lungs but also many other organs and systems in the body. It leads to various complications that go beyond respiratory symptoms, creating major challenges not only physically but also in terms of participation and involvement for patients and their caregivers. The lack of validated tools in French to specifically assess the quality of life of caregivers in this context represents a gap that this study seeks to fill. This study is also justified by the fact that, although the QASCI has been validated in other languages and context

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Being a caregiver of a relative with COPD (according to the GOLD criteria). * Being 18 years old or older. * The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month). * Being a family member of the patient or living with the patient. * Being able to complete the French questionnaires. * Non-opposition statement provided. NON-INCLUSION CRITERIA * Person under judicial protection (guardianship, curatorship, etc.) * Refusal to participate * The patient under the caregiver's care has experienced an exacerbation in the previous month * The caregiver reports that the patient has cognitive impairments.
๐Ÿ’Š

What it tests

  • questionnaire
๐Ÿ“

Where

2 sites
Chu Brest
Brest, France
Centre hospitalier de Morlaix
Morlaix, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy